EP1845990 - Bibliographic data

TREATMENT OF METASTASIZED TUMORS

Last update	02/06/2025
Legal status	Brevet déchu
Origin	Euro-PCT

(73) Holder	NOVARTIS VACCINES AND DIAGNOSTICS, INC. Intellectual Property - R440 P.O. Box 8097 Emeryville, CA 94662-8097 États-Unis d'Amérique
(72) Inventors	LOPES DE MENEZES, Daniel, c/o Chiron Corporation Intellectual Property-R440, P.O. Box 8097 Emeryville, CA 94662-8097 États-Unis d'Amérique HEISE, Carla, c/o Chiron Corporation Intellectual Property-R440, P.O. Box 8097 Emeryville, CA 94662-8097 États-Unis d'Amérique XIN, Xiaohua, c/o Chiron Corporation Intellectual Property-R440, P.O. Box 8097 Emeryville, CA 94662-8097 États-Unis d'Amérique
(74) Agent	Mail recipient LARDANS, VINCA RAYMONDE Novartis Pharma AG Patent Department 4002 Basel Suisse

(21) Request number	EP06733986.1
(22) Request date	27/01/2006

(11) Publication number	EP1845990
Publication date	28/09/2011

(54) Title of the invention	TREATMENT OF METASTASIZED TUMORS
(51) International classification	A61K 31/497, A61P 35/00
International classification (before reform)	None

Claimed priority	(31) Number: 647568 P (32) Date: 27/01/2005 (33) Country: US (31) Number: 669245 P (32) Date: 06/04/2005 (33) Country: US (31) Number: 722053 P (32) Date: 29/09/2005 (33) Country: US
Initial application	None
Divisional application	EP10186757.0 /EP2301546 None

Expected annuity	Annuity: 7 - Amount: 90 € - Due date 31/01/2012 Surtax: 7 - Amount: 18 € - Due date 01/08/2012
Last annuity	None

Publication	BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2011/3, of 30/09/2011
History	Publication de la délivrance du brevet européen - Legal date 28/09/2011 Déchéance du brevet d'invention après période de grâce - Legal date 31/01/2012 Entrée en période de grâce du brevet d'invention - Legal date 31/01/2012